The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
QTI · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | QTI | BIO | VASO | AMRX |
|---|---|---|---|---|
| Moat Score (0–100) | 47 (highest) | 47 (highest) | 47 (highest) | 47 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 60 | 34 | 48 | 94 (highest) |
| Pricing power | 47 | 92 | 94 (highest) | 37 |
| Returns on capital | — | 0 | 27 (highest) | 8 |
| Balance-sheet safety | 55 (highest) | 12 | 28 | 49 |
| Capital allocation | 24 | 96 (highest) | 36 | 44 |
| No price data | No price data | 37% below value if growth stopped today | No price data | |
| Market cap | $33M | $8.6B | $33.4M | Not reported |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |